VIVEVE MEDICAL, INC. Quarterly Debt-to-equity in % from Q2 2015 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Viveve Medical, Inc. quarterly Debt-to-equity history and growth rate from Q2 2015 to Q3 2022.
  • Viveve Medical, Inc. Debt-to-equity for the quarter ending September 30, 2022 was 134 %, a 178% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 134 +85.9 +178% Sep 30, 2022
Q2 2022 81.8 +28.7 +54.1% Jun 30, 2022
Q1 2022 57 -11.5 -16.8% Mar 31, 2022
Q4 2021 45.3 -45.1 -49.9% Dec 31, 2021
Q3 2021 48.4 -26.6 -35.5% Sep 30, 2021
Q2 2021 53.1 -221 -80.6% Jun 30, 2021
Q1 2021 68.5 -15.8K -99.6% Mar 31, 2021
Q4 2020 90.4 +865 Dec 31, 2020
Q3 2020 75 +642 Sep 30, 2020
Q2 2020 274 +1.27K Jun 30, 2020
Q1 2020 15.9K +13.3K +519% Mar 31, 2020
Q4 2019 -775 -1.31K -245% Dec 31, 2019
Q3 2019 -567 -1.27K -181% Sep 30, 2019
Q2 2019 -992 -1.44K -322% Jun 30, 2019
Q1 2019 2.57K +2.25K +696% Mar 31, 2019
Q4 2018 533 +302 +131% Dec 31, 2018
Q3 2018 699 +528 +311% Sep 30, 2018
Q2 2018 447 +297 +198% Jun 30, 2018
Q1 2018 323 +175 +118% Mar 31, 2018
Q4 2017 231 -115 -33.3% Dec 31, 2017
Q3 2017 170 -56.2 -24.8% Sep 30, 2017
Q2 2017 150 -74.9 -33.3% Jun 30, 2017
Q1 2017 148 -94.3 -38.9% Mar 31, 2017
Q4 2016 346 +42.5 +14% Dec 31, 2016
Q3 2016 226 -400 -63.9% Sep 30, 2016
Q2 2016 225 -580 -72.1% Jun 30, 2016
Q1 2016 242 Mar 31, 2016
Q4 2015 304 Dec 31, 2015
Q3 2015 626 Sep 30, 2015
Q2 2015 805 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.